Warner Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Buy
3,023
+28
+0.9% +$3.79K 0.14% 94
2026
Q1
$383K Hold
2,995
0.13% 98
2025
Q4
$365K Buy
+2,995
New +$343K 0.13% 100
2025
Q1
Sell
-3,605
Closed -$325K 120
2024
Q4
$325K Sell
3,605
-965
-21% -$93.5K 0.14% 93
2024
Q3
$451K Hold
4,570
0.2% 79
2024
Q2
$424K Sell
4,570
-116
-2% -$10.4K 0.21% 79
2024
Q1
$445K Sell
4,686
-1,268
-21% -$118K 0.22% 76
2023
Q4
$532K Sell
5,954
-3,956
-40% -$294K 0.3% 66
2023
Q3
$724K Sell
9,910
-77
-0.8% -$6.15K 0.48% 46
2023
Q2
$831K Sell
9,987
-549
-5% -$45.9K 0.54% 42
2023
Q1
$803K Buy
10,536
+712
+7% +$59.1K 0.56% 41
2022
Q4
$815K Buy
9,824
+1,936
+25% +$157K 0.62% 38
2022
Q3
$626K Buy
7,888
+1,714
+28% +$145K 0.5% 41
2022
Q2
$459K Buy
6,174
+1,981
+47% +$149K 0.42% 51
2022
Q1
$377K Buy
4,193
+839
+25% +$77.5K 0.31% 57
2021
Q4
$376K Buy
+3,354
New +$405K 0.31% 52

Other funds holding XBI

Warner Financial's XBI Position: Q2 2026 in Review

Warner Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.93% in Q2 2026, buying an estimated $3.79K and bringing the position to 3,023 shares worth $478K. The position accounts for 0.14% of the portfolio, ranked #94.

Warner Financial first reported a position in XBI in Q4 2021 and has held it in 16 quarters since. The position peaked at $831K in Q2 2023. 394 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Warner Financial held 3,023 shares of State Street SPDR S&P Biotech ETF worth $478K as of Q2 2026.
  • Warner Financial bought 28 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.79K.
  • State Street SPDR S&P Biotech ETF made up 0.14% of Warner Financial's portfolio in Q2 2026, its #94 holding.
  • Warner Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 16 quarters since.
  • Warner Financial's State Street SPDR S&P Biotech ETF position peaked at $831K in Q2 2023.
  • 394 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Warner Financial's 13F filing for Q2 2026, filed 9 Jul 2026.